[HTML][HTML] Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

SM Ryckbosch, PA Wender, VS Pande - Nature communications, 2017 - nature.com
Bryostatin is in clinical trials for Alzheimer's disease, cancer, and HIV/AIDS eradication. It
binds to protein kinase C competitively with diacylglycerol, the endogenous protein kinase C …

Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

SM Ryckbosch, PA Wender… - Nature …, 2017 - ui.adsabs.harvard.edu
Bryostatin is in clinical trials for Alzheimer's disease, cancer, and HIV/AIDS eradication. It
binds to protein kinase C competitively with diacylglycerol, the endogenous protein kinase C …

Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

SM Ryckbosch, PA Wender, VS Pande - Nature Communications, 2017 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Bryostatin is in clinical trials for Alzheimer's
disease, cancer, and HIV/AIDS eradication. It binds to protein kinase C competitively with …

Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

SM Ryckbosch, PA Wender… - Nature …, 2017 - econpapers.repec.org
Bryostatin is in clinical trials for Alzheimer's disease, cancer, and HIV/AIDS eradication. It
binds to protein kinase C competitively with diacylglycerol, the endogenous protein kinase C …

Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

SM Ryckbosch, PA Wender, VS Pande - Nature Communications, 2017 - ideas.repec.org
Bryostatin is in clinical trials for Alzheimer's disease, cancer, and HIV/AIDS eradication. It
binds to protein kinase C competitively with diacylglycerol, the endogenous protein kinase C …

Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

SM Ryckbosch, PA Wender… - Nature …, 2017 - pubmed.ncbi.nlm.nih.gov
Bryostatin is in clinical trials for Alzheimer's disease, cancer, and HIV/AIDS eradication. It
binds to protein kinase C competitively with diacylglycerol, the endogenous protein kinase C …

[PDF][PDF] Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

SM Ryckbosch, PA Wender, VS Pande - cyberleninka.org
Simulations of the PKCδ C1b domain with each one of four bound ligands (Fig. 1: bryostatin
(1), phorbol 12, 13-dibutyrate (PDBu, 2), a bryostatin analog (3) 32, and prostratin (4)) as …

Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes.

SM Ryckbosch, PA Wender… - Nature …, 2017 - search.ebscohost.com
Bryostatin is in clinical trials for Alzheimer's disease, cancer, and HIV/AIDS eradication. It
binds to protein kinase C competitively with diacylglycerol, the endogenous protein kinase C …

[HTML][HTML] Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes

SM Ryckbosch, PA Wender, VS Pande - Nature Communications, 2017 - ncbi.nlm.nih.gov
Bryostatin is in clinical trials for Alzheimer's disease, cancer, and HIV/AIDS eradication. It
binds to protein kinase C competitively with diacylglycerol, the endogenous protein kinase C …

Molecular dynamics simulations reveal ligand-controlled positioning of a peripheral protein complex in membranes.

SM Ryckbosch, PA Wender, VS Pande - Nature Communications, 2017 - europepmc.org
Bryostatin is in clinical trials for Alzheimer's disease, cancer, and HIV/AIDS eradication. It
binds to protein kinase C competitively with diacylglycerol, the endogenous protein kinase C …